Literature DB >> 3826073

Severe metabolic alkalosis complicating regional citrate hemodialysis.

S P Kelleher, G Schulman.   

Abstract

Regional citrate hemodialysis has been effectively used as an alternative to heparin anticoagulation during dialysis of patients at increased risk for bleeding. Few complications have been noted; however, we report the occurrence of severe metabolic alkalosis in two patients requiring high infusion rates of citrate during hemodialysis while being mechanically ventilated. Careful monitoring of acid-base status is mandatory in this setting, and reduction of citrate dose may be advisable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826073     DOI: 10.1016/s0272-6386(87)80061-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Low-dose and heparin-free hemodialysis in children.

Authors:  D F Geary; M Gajaria; S Fryer-Keene; J Willumsen
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 2.  What are the anticoagulation options for intermittent hemodialysis?

Authors:  Andrew Davenport
Journal:  Nat Rev Nephrol       Date:  2011-07-05       Impact factor: 28.314

3.  Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.

Authors:  John A Clark; Gerald Schulman; Thomas A Golper
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

4.  Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit.

Authors:  Andrew Davenport; Ashita Tolwani
Journal:  NDT Plus       Date:  2009-09-25

5.  Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study.

Authors:  Shaikh A Nurmohamed; Borefore P Jallah; Marc G Vervloet; Gul Yldirim; Pieter M ter Wee; A B Johan Groeneveld
Journal:  BMC Nephrol       Date:  2013-04-18       Impact factor: 2.388

6.  Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.

Authors:  Bruno Guéry; Corinne Alberti; Aude Servais; Elarbi Harrami; Lynda Bererhi; Brigitte Zins; Malik Touam; Dominique Joly
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

7.  Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?

Authors:  Chloé Medrano; Olivier Cointault; Laurence Lavayssiere; Marie-Béatrice Nogier; Eloïse Colliou; Nicolas Setbon; Nassim Kamar; Stanislas Faguer
Journal:  Clin Kidney J       Date:  2021-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.